Bluejay Diagnostics Files Definitive Proxy Statement

TL;DR

Bluejay Diagnostics proxy filed, shareholders vote on directors & auditors June 18.

AI Summary

Bluejay Diagnostics, Inc. filed its definitive proxy statement on May 16, 2025, for its annual meeting of stockholders scheduled for June 18, 2025. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key items likely include the election of directors and ratification of independent auditors.

Why It Matters

This filing provides shareholders with crucial information to make informed voting decisions on company leadership and strategic direction at the upcoming annual meeting.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) that provides information to shareholders and does not inherently represent new financial risk.

Key Numbers

• DEF 14A — Filing Type (Definitive Proxy Statement)

Key Players & Entities

• Bluejay Diagnostics, Inc. (company) — Registrant
• 0001213900-25-044931 (filing_id) — Accession Number
• 20250516 (date) — Filing Date
• 20250618 (date) — Meeting Date

FAQ

From the Filing

0001213900-25-044931.txt : 20250516 0001213900-25-044931.hdr.sgml : 20250516 20250516170034 ACCESSION NUMBER: 0001213900-25-044931 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250618 FILED AS OF DATE: 20250516 DATE AS OF CHANGE: 20250516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bluejay Diagnostics, Inc. CENTRAL INDEX KEY: 0001704287 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 473552922 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41031 FILM NUMBER: 25960288 BUSINESS ADDRESS: STREET 1: 360 MASSACHUSETTS AVENUE, SUITE 203 CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: (978) 631-0152 MAIL ADDRESS: STREET 1: 360 MASSACHUSETTS AVENUE, SUITE 203 CITY: ACTON STATE: MA ZIP: 01720 DEF 14A 1 ea0240857-02.htm PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________________ SCHEDULE 14A (Rule 14a-101) ______________________________________ INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.       ) Filed by the Registrant   ☒ Filed by a Party other than the Registrant   ☐ Check the appropriate box: ☐   Preliminary Proxy Statement ☐   Confidential, for Use of the Commission Only (as permitted by Rule 14a -6 (e)(2)) ☒   Definitive Proxy Statement ☐   Definitive Additional Materials ☐   Soliciting Material Pursuant to §240.14a -12 Bluejay Diagnostics, Inc. (Name of Registrant as Specified In Its Charter) _________________________________________________________________ (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): ☒   No fee required. ☐   Fee paid previously with preliminary materials. ☐   Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a -6 (i)(1) and 0 -11   Table of Contents Bluejay Diagnostics, Inc. 360 Massachusetts Avenue, Suite 203 Acton, MA 01720 (844) 327-7078 To the Stockholders of Bluejay Diagnostics, Inc.: You are cordially invited to attend the Annual Meeting of Stockholders of Bluejay Diagnostics, Inc. on June 18, 2025. The Annual Meeting will begin at 1:00 p.m. local time at the corporate offices of Bluejay Diagnostics, Inc., 360 Massachusetts Avenue, Suite 203, Acton, MA 01720. Information regarding each of the matters to be voted on at the Annual Meeting is contained in the attached Proxy Statement and Notice of Annual Meeting of Stockholders. We urge you to read the proxy statement carefully. The proxy statement and proxy card are being mailed to all stockholders of record as of May 15, 2025. This proxy statement and proxy card are being distributed on or about May 22, 2025. Because it is important that your shares be voted at the Annual Meeting, we urge you to complete, date and sign the enclosed proxy card and return it as promptly as possible in the accompanying envelope, whether or not you plan to attend in person. Even after returning your proxy, if you are a stockholder of record and do attend the meeting and wish to vote your shares in person, you still may do so. We look forward to seeing you on June 18, 2025. Very truly yours, BLUEJAY DIAGNOSTICS, INC.     By:   /s/ Neil Dey         Neil Dey         Chief Executive Officer     Important Notice Regarding the Availability of Proxy Materials for the Annual Shareholder Meeting to be Held on June 18, 2025: Electronic Copies of the Proxy Statement and our